Literature DB >> 26365487

Sulforaphane is anticonvulsant and improves mitochondrial function.

Catalina Carrasco-Pozo1,2, Kah Ni Tan1, Karin Borges1.   

Abstract

The nuclear factor erythroid 2-related factor 2 pathway (Nrf2) has been previously identified to protect the brain against various impacts. Here, we investigated the effect of the Nrf2 activator sulforaphane in various seizure models and hippocampal mitochondrial bioenergetics. We found that daily injections of sulforaphane for 5 days elevated the seizure thresholds to 6 Hz stimulation and fluorothyl-, but not pentylenetetrazole-induced tonic seizures and protected mice against pilocarpine-induced status epilepticus (SE). Also, sulforaphane increased the antioxidant defences within hippocampal formations and blood plasma. In addition, sulforaphane treatment reduced the extent of hippocampal lipid peroxidation 24 h post-SE and protected hippocampal mitochondria against SE-induced reduction in state 2 and uncoupler-stimulated state 3 respiration. SE-mediated partial loss of rotenone-sensitive and complex II-driven respiration was reduced, consistent with the enhanced activities of complexes I and II in sulforaphane-treated SE mice. In mitochondria isolated from both no SE and SE mice, sulforaphane increased state 3 respiration and respiration linked to ATP synthesis, which may contribute to its anticonvulsant and antioxidant effects by providing more ATP for cellular vital and protective functions. However, sulforaphane did not prevent SE-induced hippocampal cell death. In conclusion, sulforaphane and/or Nrf2 activation are viable anticonvulsant strategies, which are antioxidant and enhance mitochondrial function, especially the ability to produce ATP. Sulforaphane was anticonvulsant in two acute mouse models of epilepsy and protected mice against pilocarpine-induced status epilepticus (SE). We also found antioxidant effects of sulforaphane in mouse plasma and hippocampal formations, exhibited by increased catalase and superoxide dismutase (SOD) activity, as well as increased abilities of hippocampal mitochondria to produce ATP. These effects likely underlie sulforaphane's anticonvulsant mechanisms of action.
© 2015 International Society for Neurochemistry.

Entities:  

Keywords:  Nrf2; epilepsy; mitochondrial respiration; pilocarpine; seizure; sulforaphane

Mesh:

Substances:

Year:  2015        PMID: 26365487     DOI: 10.1111/jnc.13361

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function.

Authors:  Kah Ni Tan; Catalina Carrasco-Pozo; Tanya S McDonald; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 2.  Effects of sulforaphane on brain mitochondria: mechanistic view and future directions.

Authors:  Fernanda Rafaela Jardim; Fhelipe Jolner Souza de Almeida; Matheus Dargesso Luckachaki; Marcos Roberto de Oliveira
Journal:  J Zhejiang Univ Sci B       Date:  2020 Apr.       Impact factor: 3.066

3.  Anticonvulsant Effect of Swertiamarin Against Pilocarpine-Induced Seizures in Adult Male Mice.

Authors:  Xian-Hua Deng; Xiao Zhang; Jing Wang; Peng-Sheng Ma; Lin Ma; Yang Niu; Tao Sun; Ru Zhou; Jian-Qiang Yu
Journal:  Neurochem Res       Date:  2017-07-05       Impact factor: 3.996

4.  Current potential health benefits of sulforaphane.

Authors:  Jae Kwang Kim; Sang Un Park
Journal:  EXCLI J       Date:  2016-10-13       Impact factor: 4.068

Review 5.  Metabolic and Homeostatic Changes in Seizures and Acquired Epilepsy-Mitochondria, Calcium Dynamics and Reactive Oxygen Species.

Authors:  Stjepana Kovac; Albena T Dinkova Kostova; Alexander M Herrmann; Nico Melzer; Sven G Meuth; Ali Gorji
Journal:  Int J Mol Sci       Date:  2017-09-08       Impact factor: 5.923

6.  Sulforaphane Protects against High Cholesterol-Induced Mitochondrial Bioenergetics Impairments, Inflammation, and Oxidative Stress and Preserves Pancreatic β-Cells Function.

Authors:  Catalina Carrasco-Pozo; Kah Ni Tan; Martin Gotteland; Karin Borges
Journal:  Oxid Med Cell Longev       Date:  2017-03-12       Impact factor: 6.543

7.  The deleterious effect of cholesterol and protection by quercetin on mitochondrial bioenergetics of pancreatic β-cells, glycemic control and inflammation: In vitro and in vivo studies.

Authors:  Catalina Carrasco-Pozo; Kah Ni Tan; Marjorie Reyes-Farias; Nicole De La Jara; Shyuan Thieu Ngo; Diego Fernando Garcia-Diaz; Paola Llanos; Maria Jose Cires; Karin Borges
Journal:  Redox Biol       Date:  2016-08-26       Impact factor: 11.799

8.  Alterations in Cytosolic and Mitochondrial [U-13C]Glucose Metabolism in a Chronic Epilepsy Mouse Model.

Authors:  Tanya S McDonald; Catalina Carrasco-Pozo; Mark P Hodson; Karin Borges
Journal:  eNeuro       Date:  2017-03-09

Review 9.  Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof.

Authors:  Tanya McDonald; Michelle Puchowicz; Karin Borges
Journal:  Front Cell Neurosci       Date:  2018-08-31       Impact factor: 5.505

Review 10.  Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer's Disease.

Authors:  Chanchal Sharma; Sehwan Kim; Youngpyo Nam; Un Ju Jung; Sang Ryong Kim
Journal:  Int J Mol Sci       Date:  2021-05-03       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.